Last updated: July 26, 2026
Personal Audio, LLC v. Apple, Inc. (9:09-cv-00111): Litigation Summary, Claims at Issue, and Patent-Strategy Impact
Personal Audio, LLC v. Apple, Inc., No. 9:09-cv-00111 (federal district court), is a patent infringement case. The docket identifier provided is consistent with a long-running, multi-asset Apple intellectual property dispute, but no specific claims, asserted patents, procedural posture, claim construction rulings, or dispositive outcomes are provided in the input. Without those particulars, a complete litigation summary and enforcement/validity analysis cannot be produced accurately.
What patents were asserted in Personal Audio, LLC v. Apple, Inc. (9:09-cv-00111)?
A litigation summary requires the asserted patent numbers, the technology claim elements, and the asserted Apple products (e.g., iPod, iPhone, iTunes software, Apple’s audio playback workflows, or related streaming features). Those data are not included in the request.
What products and features were accused in the Apple infringement case?
A credible infringement analysis depends on the accused instrumentalities listed in the complaint and amended pleadings (model lines, software components, operating systems, and feature mappings to claim limitations). This information is not included.
What procedural events shaped the case timeline (motions, claim construction, trial, appeal)?
A litigation timeline depends on docket events such as:
- complaint filing and service milestones
- amended complaints and schedules
- Markman/claim construction dates
- summary judgment rulings
- Daubert rulings
- trial dates and verdicts
- post-trial orders
- appellate disposition
No procedural docket events are provided.
What did the court decide on claim construction and infringement?
A claim construction and infringement analysis requires the court’s constructions for disputed claim terms and the court’s application to the accused features. Those decisions are not included.
Were there any Paragraph IV or Orange Book exclusivity issues?
This matter appears to be a patent infringement dispute, not an FDA regulatory exclusivity dispute. Orange Book and Paragraph IV issues apply to small-molecule generic entry or 505(b)(2) or ANDA exclusivity triggers, and those are not relevant unless the pleadings identify an FDA pathway or drug-product listing dispute. No such information is provided.
How did settlement, dismissal, or injunction outcomes affect IP risk?
An IP risk analysis depends on the final judgment or settlement terms, including:
- whether Apple obtained a dismissal with prejudice
- whether any patents were held invalid or not infringed
- whether a covenant not to sue issued
- whether damages were awarded
- whether royalties were agreed
- whether a stay or ongoing license was implemented
No disposition or settlement terms are provided.
Which parties controlled the case and who owned the asserted patent rights?
A business-relevant litigation map requires:
- the patent owner(s) and assignee(s)
- named inventors and continuation relationships
- entity ownership and licensing structure
- whether Personal Audio is the assignee of record
No ownership or asserted-asset details are provided.
How strong was Personal Audio’s patent estate in this case versus Apple’s invalidity posture?
Strength analysis needs:
- asserted claims and independent/dependent structure
- anticipated prior art categories (platform audio patents, streaming, playback metadata, device controls)
- invalidity invalidity theories (anticipation, obviousness, indefiniteness, written description)
- how claim construction narrowed the scope
No asserted claims or prior art positions are provided.
What generic-style “design-around” or product redesign risk existed for Apple?
This requires:
- the specific claim elements allegedly met
- design-around opportunities identified in claim charts or expert reports
- whether Apple implemented alternative architectures
No infringement theory details are provided.
How do other Personal Audio v. Apple disputes compare for outcome predictability?
Outcome predictability requires cross-case mapping:
- same asserted patents or continuations
- same claim constructions reused
- similar accused features
No cross-reference case list or shared patents are provided.
Key Takeaways
- The case caption and docket number alone are insufficient to produce an accurate litigation summary or enforceability/validity analysis.
- A complete business-facing analysis requires asserted patent identifiers, accused products, procedural chronology, and dispositive outcomes, none of which are included in the request.
FAQs
-
What information is needed to summarize a patent case docket accurately?
Complaint-identified asserted patents, accused instrumentalities, and key docket events are required.
-
Does docket numbering 9:09-cv-00111 reveal the asserted patents automatically?
No. Docket numbers index the case, not the asserted assets.
-
How are claim construction decisions used in infringement and invalidity analysis?
Constructions constrain claim scope and drive both infringement mapping and prior-art comparisons.
-
What outcomes typically drive settlement in Apple patent suits?
Claim construction, summary judgment risk, and perceived invalidity exposure.
-
When can a patent case end without a final merits decision?
Parties may dismiss, settle, or obtain procedural dispositions without reaching claim-level findings.
References
No sources were cited because the request did not include asserted patents, docket events, or case documents necessary for citation-grade reporting.
